Ying‐zi Xu

592 total citations
21 papers, 347 citations indexed

About

Ying‐zi Xu is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Ying‐zi Xu has authored 21 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Ying‐zi Xu's work include Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (4 papers) and Chemical Synthesis and Analysis (3 papers). Ying‐zi Xu is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (4 papers) and Chemical Synthesis and Analysis (3 papers). Ying‐zi Xu collaborates with scholars based in United States, China and Canada. Ying‐zi Xu's co-authors include Kenichi Yakushijin, Gary D. Probst, David Horne, Christopher T. Jones, Martijn Fenaux, Randall L. Halcomb, F. Anthony Romero, Sean Turner, Manuel Calaza and Henry Rapoport and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Hepatology.

In The Last Decade

Ying‐zi Xu

19 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying‐zi Xu United States 11 150 133 66 63 59 21 347
Yanshen Guo China 10 112 0.7× 205 1.5× 56 0.8× 22 0.3× 37 0.6× 20 335
Wenhai Huang China 13 69 0.5× 181 1.4× 124 1.9× 60 1.0× 84 1.4× 33 463
Ravi Naik South Korea 11 190 1.3× 264 2.0× 60 0.9× 28 0.4× 17 0.3× 20 529
Carmen Cascales Spain 11 60 0.4× 219 1.6× 130 2.0× 41 0.7× 13 0.2× 20 479
Hitoshi Kurata Japan 13 126 0.8× 150 1.1× 40 0.6× 14 0.2× 18 0.3× 21 343
Alan M. Birch United Kingdom 11 191 1.3× 165 1.2× 32 0.5× 42 0.7× 33 0.6× 20 402
Hongchan An South Korea 14 180 1.2× 228 1.7× 57 0.9× 34 0.5× 18 0.3× 35 482
Kshitij Thakkar United States 10 188 1.3× 143 1.1× 76 1.2× 33 0.5× 8 0.1× 11 458
Alfred Binggeli Switzerland 10 102 0.7× 325 2.4× 38 0.6× 61 1.0× 102 1.7× 10 509
Masakazu Sato Japan 14 295 2.0× 170 1.3× 65 1.0× 83 1.3× 22 0.4× 27 721

Countries citing papers authored by Ying‐zi Xu

Since Specialization
Citations

This map shows the geographic impact of Ying‐zi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐zi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐zi Xu more than expected).

Fields of papers citing papers by Ying‐zi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐zi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐zi Xu. The network helps show where Ying‐zi Xu may publish in the future.

Co-authorship network of co-authors of Ying‐zi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐zi Xu. A scholar is included among the top collaborators of Ying‐zi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐zi Xu. Ying‐zi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Yan, et al.. (2024). A case report of adenomyosis-induced spontaneous rupture in an unscarred and unpregnant uterus. Medicine. 103(51). e41037–e41037.
3.
Kirschberg, Thorsten, Christopher T. Jones, Ying‐zi Xu, et al.. (2020). Selective thyroid hormone receptor β agonists with oxadiazolone acid isosteres. Bioorganic & Medicinal Chemistry Letters. 30(21). 127465–127465. 5 indexed citations
4.
Chang, Xiao-Wen, et al.. (2020). On the Randomized Babai Point. 1195–1200. 2 indexed citations
5.
Klucher, Kevin, Yujin Wang, Ying‐zi Xu, Randall L. Halcomb, & Martijn Fenaux. (2019). FRI-314-A novel semicarbazide-sensitive amine oxidase inhibitor, TERN-201, reduces NAS and fibrosis in rodent models of non-alcoholic steatohepatitis. Journal of Hepatology. 70(1). e534–e535. 1 indexed citations
7.
Ren, Zhao, Danny Tam, Ying‐zi Xu, et al.. (2013). Development of a Novel β-Secretase Binding Assay Using the AlphaScreen Platform. SLAS DISCOVERY. 18(6). 695–704. 6 indexed citations
8.
Xu, Ying‐zi, Shendong Yuan, Simeon Bowers, et al.. (2013). Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(10). 3075–3080. 21 indexed citations
9.
Mondal, Kalyani, Karin Regnström, Robin Barbour, et al.. (2013). Thermodynamic and kinetic characterization of hydroxyethylamine β-secretase-1 inhibitors. Biochemical and Biophysical Research Communications. 441(2). 291–296. 5 indexed citations
10.
Bowers, Simeon, Ying‐zi Xu, Shendong Yuan, et al.. (2013). Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates. Bioorganic & Medicinal Chemistry Letters. 23(7). 2181–2186. 10 indexed citations
11.
Probst, Gary D. & Ying‐zi Xu. (2012). Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011). Expert Opinion on Therapeutic Patents. 22(5). 511–540. 60 indexed citations
12.
Chen, Linda, Mark Dreyer, Stephen B. Freedman, et al.. (2011). Discovery of a potent, orally bioavailable pyrimidine VLA-4 antagonist effective in a sheep asthma model. Bioorganic & Medicinal Chemistry Letters. 21(6). 1741–1743. 4 indexed citations
13.
Bova, Michael P., et al.. (2011). A Label-Free Approach to Identify Inhibitors of α4β7-Mediated Cell Adhesion to MadCAM. SLAS DISCOVERY. 16(5). 536–544. 2 indexed citations
14.
Konradi, Andrei W., Ying‐zi Xu, Albert W. Garofalo, et al.. (2010). Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and Efficacious γ-Secretase Inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(7). 2195–2199. 14 indexed citations
15.
Xu, Ying‐zi, Jaesung Choi, Manuel Calaza, Sean Turner, & Henry Rapoport. (1999). Conformationally Constrained Nicotines. 1-Pyridinyl-7-azabicyclo[2.2.1]heptane and 1-Pyridinyl-8-azabicyclo[3.2.1]octane Analogues. The Journal of Organic Chemistry. 64(11). 4069–4078. 32 indexed citations
16.
Xu, Ying‐zi, Kenichi Yakushijin, & David Horne. (1997). Synthesis of C11N5 Marine Sponge Alkaloids:  (±)-Hymenin, Stevensine, Hymenialdisine, and Debromohymenialdisine. The Journal of Organic Chemistry. 62(3). 456–464. 55 indexed citations
17.
Xu, Ying‐zi, et al.. (1996). Transbromination of brominated pyrrole and imidazole derivatives: Synthesis of the C11N5 marine alkaloid stevensine. Tetrahedron Letters. 37(45). 8121–8124. 10 indexed citations
18.
Xu, Ying‐zi, Kenichi Yakushijin, & David Horne. (1996). Oxidative Dimerization of 2-Aminoimidazoles by Molecular Bromine. Synthesis of Parazoanthoxanthin A. The Journal of Organic Chemistry. 61(26). 9569–9571. 17 indexed citations
19.
Xu, Ying‐zi, et al.. (1994). A synthesis of (±)-hymenin. Tetrahedron Letters. 35(3). 351–354. 10 indexed citations
20.
Xu, Ying‐zi, Kenichi Yakushijin, & David Horne. (1993). Reactions of 2-aminoimidazoles with aldehydes. Hydroxyalkylation and cycloaddition.. Tetrahedron Letters. 34(44). 6981–6984. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026